AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
US9457077B2
(en)
|
2009-11-18 |
2016-10-04 |
Katherine Rose Kovarik |
Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
|
US9585920B2
(en)
|
2011-02-04 |
2017-03-07 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
DK3564357T3
(da)
|
2010-02-01 |
2022-06-20 |
Rebiotix Inc |
Bakterieterapi mod clostridium difficile colitis
|
KR20130098320A
(ko)
|
2010-08-04 |
2013-09-04 |
토마스 줄리어스 보로디 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
US9987224B2
(en)
|
2011-02-04 |
2018-06-05 |
Joseph E. Kovarik |
Method and system for preventing migraine headaches, cluster headaches and dizziness
|
US10583033B2
(en)
|
2011-02-04 |
2020-03-10 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US10314865B2
(en)
|
2011-02-04 |
2019-06-11 |
Katherine Rose Kovarik |
Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
|
US10010568B2
(en)
|
2011-02-04 |
2018-07-03 |
Katherine Rose Kovarik |
Method and system for reducing the likelihood of a spirochetes infection in a human being
|
US11419903B2
(en)
|
2015-11-30 |
2022-08-23 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US10111913B2
(en)
|
2011-02-04 |
2018-10-30 |
Joseph E. Kovarik |
Method of reducing the likelihood of skin cancer in an individual human being
|
US10085938B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for preventing sore throat in humans
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US10086018B2
(en)
|
2011-02-04 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
US11191665B2
(en)
|
2011-02-04 |
2021-12-07 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
|
US11523934B2
(en)
|
2011-02-04 |
2022-12-13 |
Seed Health, Inc. |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US10512661B2
(en)
|
2011-02-04 |
2019-12-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US11357722B2
(en)
|
2011-02-04 |
2022-06-14 |
Seed Health, Inc. |
Method and system for preventing sore throat in humans
|
US10548761B2
(en)
|
2011-02-04 |
2020-02-04 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of colorectal cancer in a human being
|
US11273187B2
(en)
|
2015-11-30 |
2022-03-15 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing depression in an individual
|
US10835560B2
(en)
|
2013-12-20 |
2020-11-17 |
Joseph E. Kovarik |
Reducing the likelihood of skin cancer in an individual human being
|
US9730967B2
(en)
|
2011-02-04 |
2017-08-15 |
Katherine Rose Kovarik |
Method and system for treating cancer cachexia
|
US10842834B2
(en)
|
2016-01-06 |
2020-11-24 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
|
US10245288B2
(en)
|
2011-02-04 |
2019-04-02 |
Joseph E. Kovarik |
Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
|
US10940169B2
(en)
|
2015-11-30 |
2021-03-09 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing cancer in an individual human being
|
US10687975B2
(en)
|
2011-02-04 |
2020-06-23 |
Joseph E. Kovarik |
Method and system to facilitate the growth of desired bacteria in a human's mouth
|
EP2683390B1
(en)
|
2011-03-09 |
2017-05-03 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
DK2850202T3
(da)
*
|
2012-05-18 |
2020-05-18 |
Genome Res Ltd |
Fremgangsmåder og grupper
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
JP6479685B2
(ja)
|
2013-02-04 |
2019-03-06 |
セレス セラピューティクス インコーポレイテッド |
病原性細菌生育の抑制のための組成物および方法
|
CA2906921A1
(en)
|
2013-03-15 |
2014-09-18 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
WO2014196913A1
(en)
*
|
2013-06-03 |
2014-12-11 |
Björck Inger |
Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
EP4234011A3
(en)
|
2013-06-05 |
2023-09-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
JP6833514B2
(ja)
|
2013-11-25 |
2021-02-24 |
セレス セラピューティクス インコーポレイテッド |
相乗作用のある細菌組成物ならびにその製造及び使用方法
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
US11642382B2
(en)
|
2013-12-20 |
2023-05-09 |
Seed Health, Inc. |
Method for treating an individual suffering from bladder cancer
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11672835B2
(en)
|
2013-12-20 |
2023-06-13 |
Seed Health, Inc. |
Method for treating individuals having cancer and who are receiving cancer immunotherapy
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
US11213552B2
(en)
|
2015-11-30 |
2022-01-04 |
Joseph E. Kovarik |
Method for treating an individual suffering from a chronic infectious disease and cancer
|
US11529379B2
(en)
|
2013-12-20 |
2022-12-20 |
Seed Health, Inc. |
Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
|
US11026982B2
(en)
|
2015-11-30 |
2021-06-08 |
Joseph E. Kovarik |
Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
CA2949232A1
(en)
*
|
2014-05-19 |
2015-11-26 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
FI127671B
(en)
*
|
2014-05-28 |
2018-11-30 |
Filip Scheperjans |
Procedure for the diagnosis of Parkinson's disease
|
EP2995314A1
(en)
*
|
2014-09-12 |
2016-03-16 |
Swecure AB |
Use of collinsella for treatment of inflammatory bowel disease
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
JP6393425B2
(ja)
|
2014-12-08 |
2018-09-19 |
ジ アサン ファウンデーション |
バクテロイデス・アシジファシエンスを有効成分として含む、代謝性疾患の予防又は治療用薬学的組成物
|
KR102523805B1
(ko)
|
2014-12-23 |
2023-04-20 |
4디 파마 리서치 리미티드 |
면역 조정
|
EP3400953A1
(en)
|
2014-12-23 |
2018-11-14 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
SE1550189A1
(en)
*
|
2015-02-19 |
2016-08-20 |
Achim Biotherapeutics Ab |
Therapeutic and prophylactic composition produced by microbiota
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
CA2979086A1
(en)
*
|
2015-03-12 |
2016-09-15 |
The University Of British Columbia |
Bacterial compositions and methods of use thereof
|
WO2016164402A1
(en)
*
|
2015-04-06 |
2016-10-13 |
Oklahoma Medical Research Foundation |
Methods of diagnosing and treating autoimmune disease
|
EP3294308A4
(en)
|
2015-05-14 |
2019-03-06 |
University of Puerto Rico |
PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
|
EP3294307A4
(en)
|
2015-05-14 |
2019-01-23 |
Crestovo Holdings Llc |
COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
|
NZ776366A
(en)
|
2015-05-22 |
2023-02-24 |
Univ Minnesota |
Methods for treating autism spectrum disorder and associated symptoms
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US20180153944A1
(en)
*
|
2015-06-09 |
2018-06-07 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
AU2016274757B2
(en)
|
2015-06-09 |
2019-02-07 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
PT3307288T
(pt)
|
2015-06-15 |
2019-10-17 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
DK3206700T3
(da)
|
2015-06-15 |
2019-08-05 |
4D Pharma Res Ltd |
Sammensætninger omfattende bakteriestammer
|
PT3240554T
(pt)
|
2015-06-15 |
2019-11-04 |
4D Pharma Res Ltd |
Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
|
KR101914245B1
(ko)
|
2015-11-20 |
2018-11-02 |
4디 파마 리서치 리미티드 |
박테리아성 균주를 함유한 조성물
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
US11529412B2
(en)
|
2015-11-30 |
2022-12-20 |
Seed Health, Inc. |
Method and system for protecting honey bees from pesticides
|
US10568916B2
(en)
|
2015-11-30 |
2020-02-25 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
US10933128B2
(en)
|
2015-11-30 |
2021-03-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees from pesticides
|
US10675347B2
(en)
|
2015-11-30 |
2020-06-09 |
Joseph E. Kovarik |
Method and system for protecting honey bees from fipronil pesticides
|
US10086024B2
(en)
|
2015-11-30 |
2018-10-02 |
Joseph E. Kovarik |
Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
|
FR3045383B1
(fr)
|
2015-12-18 |
2019-06-14 |
Maat Pharma |
Procede de lyophilisation d'un echantillon de microbiote fecal
|
WO2017117142A1
(en)
|
2015-12-28 |
2017-07-06 |
New York University |
Device and method of restoring microbiota of newborns
|
CN105603066B
(zh)
*
|
2016-01-13 |
2020-07-14 |
金锋 |
精神障碍的肠道微生物标志物及其应用
|
JP6573639B2
(ja)
*
|
2016-01-26 |
2019-09-11 |
富士フイルム株式会社 |
腸内細菌数抑制剤、食品、及び医薬品
|
MA42560B1
(fr)
|
2016-03-04 |
2019-07-31 |
4D Pharma Plc |
Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
KR101799830B1
(ko)
*
|
2016-06-14 |
2017-11-21 |
한국생명공학연구원 |
퇴행성 뇌질환의 예방 또는 치료 효과를 가지는 아가토바쿨룸 속 균주 및 이의 용도
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
CN106361777A
(zh)
*
|
2016-11-28 |
2017-02-01 |
青岛东海药业有限公司 |
酪酸梭菌在制备预防或治疗孤独症制剂中的应用
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
AU2018250206A1
(en)
|
2017-04-05 |
2019-10-31 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (PD) and related disorders
|
EP3388069B1
(en)
|
2017-04-12 |
2019-05-01 |
ETH Zurich |
Consortia of living bacteria useful for treatment of microbiome dysbiosis
|
CN107126445A
(zh)
*
|
2017-04-20 |
2017-09-05 |
江南大学 |
粪菌移植在治疗帕金森病方面的应用
|
TW201907928A
(zh)
|
2017-05-22 |
2019-03-01 |
英商4D製藥研究有限公司 |
包含細菌品系之組成物
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
CA3063508A1
(en)
*
|
2017-05-26 |
2018-11-29 |
Holly H. Ganz |
Products and methods for therapeutic administration of microorganisms to non-human animals
|
AU2018272048B2
(en)
|
2017-05-26 |
2024-04-04 |
Finch Therapeutics Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
CN107115363A
(zh)
*
|
2017-06-05 |
2017-09-01 |
青岛东海药业有限公司 |
凝结芽孢杆菌在制备预防或治疗慢性疲劳综合征制剂中的应用
|
RS61367B1
(sr)
*
|
2017-06-14 |
2021-02-26 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
MA49425A
(fr)
|
2017-06-14 |
2020-04-22 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
ES2841902T3
(es)
|
2017-06-14 |
2021-07-12 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
EP3664823B1
(en)
*
|
2017-08-07 |
2024-06-05 |
Finch Therapeutics Holdings LLC |
Composition for use in preventing or treating an enterococcal blood stream infection
|
EP3668527A1
(en)
|
2017-08-14 |
2020-06-24 |
Seres Therapeutics, Inc. |
Compositions and methods for treating cholestatic disease
|
KR102355054B1
(ko)
*
|
2017-10-13 |
2022-01-24 |
리바이오틱스, 인코퍼레이티드 |
마이크로바이옴 건강 지수
|
WO2019078381A1
(ko)
*
|
2017-10-18 |
2019-04-25 |
연세대학교 원주산학협력단 |
엔테로코커스 패칼리스, 이의 배양액 또는 이의 사균체를 유효성분으로 함유하는 근육감퇴, 약화 및 근위축 예방, 개선 또는 치료용 약학 조성물, 식품 조성물 및 식품첨가제
|
WO2019149859A1
(en)
*
|
2018-01-31 |
2019-08-08 |
Universität Basel |
Gut commensal bacteria for treatment of human colorectal cancer
|
AU2019224114A1
(en)
*
|
2018-02-23 |
2020-09-10 |
Finch Therapeutics Holdings Llc |
Microbiome related immunotherapies
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
CA3114423A1
(en)
|
2018-09-27 |
2020-04-02 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
KR102340392B1
(ko)
*
|
2018-10-08 |
2021-12-17 |
한국생명공학연구원 |
우울증의 예방 또는 치료 효과를 가지는 장내 미생물 및 이의 용도
|
WO2020180037A1
(ko)
*
|
2019-03-04 |
2020-09-10 |
경북대학교 산학협력단 |
인간 장내 미생물 군집 모사 배양용 조성물, 혐기 배양 체계를 이용한 인간 장내 미생물 군집의 모사 배양 방법, 이에 의해 제조된 미생물 제제 및 이의 용도
|
US11284609B2
(en)
*
|
2019-09-12 |
2022-03-29 |
MarvelBiome, Inc. |
Compositions and methods for characterizing a microbiome
|
KR20220080104A
(ko)
*
|
2019-09-13 |
2022-06-14 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
자폐 스펙트럼 장애를 치료하기 위한 조성물 및 방법
|
EP3839072A1
(en)
*
|
2019-12-17 |
2021-06-23 |
Luxia Scientific |
Bacterial combinations predictive of the activity of multiple sclerosis
|
CA3174462A1
(en)
*
|
2020-03-04 |
2021-09-10 |
Tu Biomics, Inc. |
Compositions comprising l-lactic acid and acetic acid for inhibiting fungal pathogens and methods related thereto
|